Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 10 | 2023 | 2788 | 1.390 |
Why?
|
Atrial Fibrillation | 11 | 2023 | 5188 | 1.100 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2023 | 65 | 0.850 |
Why?
|
Tachycardia, Supraventricular | 2 | 2023 | 270 | 0.830 |
Why?
|
Tachycardia, Ventricular | 2 | 2024 | 1310 | 0.590 |
Why?
|
Sleep Apnea, Central | 1 | 2017 | 88 | 0.520 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2022 | 581 | 0.470 |
Why?
|
Electric Countershock | 2 | 2019 | 534 | 0.460 |
Why?
|
Sleep Apnea Syndromes | 1 | 2022 | 983 | 0.450 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2017 | 1899 | 0.410 |
Why?
|
Electrophysiologic Techniques, Cardiac | 3 | 2024 | 511 | 0.330 |
Why?
|
Vascular System Injuries | 1 | 2013 | 246 | 0.320 |
Why?
|
Heptanoic Acids | 1 | 2009 | 344 | 0.270 |
Why?
|
Pravastatin | 1 | 2009 | 391 | 0.270 |
Why?
|
Pulmonary Veins | 1 | 2013 | 757 | 0.270 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2013 | 562 | 0.270 |
Why?
|
Aortic Diseases | 1 | 2013 | 729 | 0.270 |
Why?
|
Primary Prevention | 1 | 2013 | 1187 | 0.240 |
Why?
|
Aorta | 1 | 2013 | 2027 | 0.240 |
Why?
|
Death, Sudden, Cardiac | 1 | 2013 | 1567 | 0.230 |
Why?
|
High-Frequency Jet Ventilation | 1 | 2023 | 26 | 0.220 |
Why?
|
Acute Coronary Syndrome | 3 | 2012 | 2184 | 0.200 |
Why?
|
Pyrroles | 1 | 2009 | 1119 | 0.200 |
Why?
|
Anti-Arrhythmia Agents | 3 | 2022 | 771 | 0.200 |
Why?
|
Bed Rest | 1 | 2022 | 82 | 0.200 |
Why?
|
Atrioventricular Block | 1 | 2022 | 141 | 0.170 |
Why?
|
Amiodarone | 1 | 2021 | 216 | 0.160 |
Why?
|
Hypotension | 1 | 2023 | 885 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2022 | 827 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3251 | 0.110 |
Why?
|
Arrhythmias, Cardiac | 1 | 2023 | 2249 | 0.110 |
Why?
|
Thromboembolism | 1 | 2019 | 1003 | 0.100 |
Why?
|
Heart Ventricles | 1 | 2024 | 3831 | 0.100 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2013 | 122 | 0.100 |
Why?
|
Hemorrhage | 2 | 2022 | 3461 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2022 | 5302 | 0.090 |
Why?
|
Hirudins | 1 | 2012 | 179 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2024 | 81457 | 0.090 |
Why?
|
Treatment Outcome | 9 | 2022 | 65180 | 0.090 |
Why?
|
Postoperative Complications | 1 | 2013 | 15749 | 0.090 |
Why?
|
Cicatrix | 1 | 2016 | 797 | 0.090 |
Why?
|
Defibrillators, Implantable | 2 | 2024 | 1490 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 2023 | 0.080 |
Why?
|
Angioplasty | 1 | 2012 | 352 | 0.080 |
Why?
|
Antithrombins | 1 | 2012 | 295 | 0.080 |
Why?
|
Patient Discharge | 1 | 2022 | 3461 | 0.080 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 1978 | 0.080 |
Why?
|
Humans | 19 | 2024 | 765734 | 0.070 |
Why?
|
Gadolinium | 1 | 2013 | 965 | 0.070 |
Why?
|
Heart Atria | 1 | 2013 | 1363 | 0.070 |
Why?
|
Angina, Unstable | 1 | 2010 | 893 | 0.060 |
Why?
|
Thiophenes | 1 | 2010 | 569 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3835 | 0.060 |
Why?
|
Middle Aged | 11 | 2024 | 222903 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2010 | 800 | 0.060 |
Why?
|
Vectorcardiography | 1 | 2024 | 48 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3412 | 0.060 |
Why?
|
Risk Factors | 5 | 2022 | 74831 | 0.050 |
Why?
|
Male | 12 | 2024 | 363585 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2010 | 1727 | 0.050 |
Why?
|
Seasons | 1 | 2009 | 1522 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 5526 | 0.050 |
Why?
|
Electrocardiography | 4 | 2024 | 6401 | 0.050 |
Why?
|
Cholesterol, HDL | 1 | 2009 | 1811 | 0.050 |
Why?
|
Image Enhancement | 1 | 2013 | 2859 | 0.050 |
Why?
|
Female | 11 | 2024 | 395961 | 0.050 |
Why?
|
Sotalol | 1 | 2021 | 47 | 0.050 |
Why?
|
Adult | 7 | 2022 | 222974 | 0.050 |
Why?
|
Age Factors | 2 | 2020 | 18375 | 0.050 |
Why?
|
Flecainide | 1 | 2021 | 41 | 0.050 |
Why?
|
Aged | 7 | 2024 | 171050 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2012 | 11504 | 0.040 |
Why?
|
Piperazines | 1 | 2010 | 2546 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3242 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2009 | 2393 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2012 | 5125 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2010 | 4494 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2010 | 2771 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 131 | 0.040 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2022 | 881 | 0.040 |
Why?
|
Prognosis | 1 | 2017 | 29899 | 0.030 |
Why?
|
Prospective Studies | 2 | 2017 | 54795 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2022 | 59459 | 0.030 |
Why?
|
Needs Assessment | 1 | 2019 | 1139 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 59852 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2016 | 760 | 0.020 |
Why?
|
Aortic Valve | 1 | 2022 | 1968 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3930 | 0.020 |
Why?
|
Heart Conduction System | 1 | 2016 | 1006 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3889 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5596 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2020 | 2115 | 0.020 |
Why?
|
Creatine Kinase, MB Form | 1 | 2010 | 202 | 0.020 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2012 | 580 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3617 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2022 | 3230 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39180 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8293 | 0.020 |
Why?
|
Vascular Patency | 1 | 2010 | 912 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 88781 | 0.020 |
Why?
|
Drug Resistance | 1 | 2012 | 1591 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5368 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10567 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 36537 | 0.020 |
Why?
|
Heparin | 1 | 2012 | 1630 | 0.010 |
Why?
|
Time Factors | 2 | 2020 | 40066 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3432 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6492 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4136 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6499 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2012 | 3097 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8498 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10069 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12056 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12509 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10385 | 0.010 |
Why?
|
United States | 1 | 2020 | 72898 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 24279 | 0.000 |
Why?
|
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_